TGFB1 and carcinoma: However, in late-stage carcinomas, once cells acquire resistance to its suppressive effects, TGF-β actions switch to pro-oncogenic, conferring cell survival, inducing cell migration and invasion, mediating immune alterations and microenvironment modifications (10, 11).